Migraine is the leading neurological disease worldwide, exerting a profound impact on disability rates and quality of life across various demographics. Recent years have seen significant strides in migraine treatment, driven by an enhanced understanding of its pathophysiology and the development of novel pharmacological approaches. Despite these advancements, the full potential of these new treatments has yet to be realized within everyday clinical settings. This shortfall underscores the essential role Nurse Practitioners (NPs) play in closing the gap in migraine management, leveraging their expertise to deliver comprehensive care.
The proposed presentation is aiming to update and refine the attendees’ approach to migraine management. The program is structured around three pillars: effective diagnosis of headache subtypes with strategies to prevent misdiagnosis, critical factors in the selection of preventive migraine treatments across diverse patient profiles, and a primer on the clinical application of CGRP antagonists, a novel class of migraine medications.
This presentation further seeks to empower healthcare providers with the latest insights and practical tools to integrate cutting-edge migraine treatments into their practice, ultimately enhancing patient care in the face of this challenging neurological disease. Attendees will gain foundational knowledge in the following areas: distinguishing migraine from secondary headache disorders; recognizing indication for preventive treatment; understanding new classes of migraine treatments, particularly CGRP antagonists; and navigating patient-centred access and preference variables.
